BioCentury's websites will be down for upgrades starting at 11 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

6:46 PM
 | 
Mar 09, 2009
 |  BC Extra  |  Company News

FDA panel to discuss Avastin for glioblastoma

FDA's Oncologic Drugs Advisory Committee will meet on March 31 to discuss an sBLA from Genentech...

Read the full 64 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >